Glenmede Trust CO Na Eli Lilly & CO Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

A detailed history of Glenmede Trust CO Na transactions in Eli Lilly & CO stock. As of the latest transaction made, Glenmede Trust CO Na holds 356,296 shares of LLY stock, worth $268 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares

356,296

Previous 361,593 1.46%

Holding current value

$268 Million

Previous $327 Million 3.58%

% of portfolio

1.53%

Previous 1.67%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $4.09 Million - $5.09 Million	-5,297 Reduced 1.46%	356,296 $316 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $4.48 Million - $5.62 Million	-6,185 Reduced 1.68%	361,593 $327 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $16 Million - $21.4 Million	-27,028 Reduced 6.85%	367,778 $286 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $7.8 Million - $9.19 Million	-14,845 Reduced 3.62%	394,806 $230 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $10.8 Million - $14.8 Million	-24,757 Reduced 5.7%	409,651 $220 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $4.49 Million - $5.28 Million	-14,464 Reduced 3.22%	434,408 $149 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $1.63 Million - $1.89 Million	-5,057 Reduced 1.11%	448,872 $164 Million
Q3 2022 Nov 16, 2022	BUY	$296.48 - $337.87 $3.66 Million - $4.18 Million	12,360 Added 2.8%	453,929 $147 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $2.37 Million - $2.78 Million	-8,487 Reduced 1.89%	441,569 $143 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $10.2 Million - $12.7 Million	-43,477 Reduced 8.81%	450,056 $129 Million
Q4 2021 Feb 15, 2022	SELL	$224.85 - $279.04 $1.91 Million - $2.37 Million	-8,491 Reduced 1.69%	493,533 $136 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $1.81 Million - $2.23 Million	-8,177 Reduced 1.6%	502,024 $116 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $4.66 Million - $6.03 Million	-25,801 Reduced 4.81%	510,201 $117 Million
Q1 2021 May 18, 2021	BUY	$164.32 - $212.72 $298,569 - $386,512	1,817 Added 0.34%	536,002 $100 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $5.06 Million - $6.7 Million	38,809 Added 7.83%	534,185 $90.2 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $954,670 - $1.1 Million	-6,529 Reduced 1.3%	495,376 $73.3 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $2.34 Million - $2.82 Million	-17,168 Reduced 3.31%	501,905 $82.4 Million
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $31.9 Million - $39.5 Million	-298,422 Reduced 36.5%	519,073 $68.2 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $7.39 Million - $8.04 Million	-69,213 Reduced 7.81%	817,495 $91.4 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $8.57 Million - $10 Million	-77,311 Reduced 8.02%	886,708 $98.2 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $15.8 Million - $18.6 Million	-141,725 Reduced 12.82%	964,019 $125 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $2.39 Million - $2.68 Million	22,557 Added 2.08%	1,105,744 $128 Million
Q3 2018 Nov 15, 2018	SELL	$85.86 - $107.31 $1.55 Million - $1.94 Million	-18,033 Reduced 1.64%	1,083,187 $116 Million
Q2 2018 Aug 15, 2018	BUY	$75.7 - $86.88 $29.2 Million - $33.5 Million	385,266 Added 53.81%	1,101,220 $94 Million
Q4 2017 Feb 15, 2018	SELL	$81.94 - $87.89 $1.21 Million - $1.3 Million	-14,814 Reduced 2.03%	715,954 $60.5 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $56.3 Million - $62.5 Million	730,768	730,768 $0

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Eli Lilly & CO Transaction History